pentetic acid has been researched along with lithium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, UB; Bruun, NE; Dige-Petersen, H; Ibsen, H; Skøtt, P | 1 |
| Abergel, RJ; Bjornstad, KA; Blakely, EA; Bunin, DI; Chang, PY; Durbin, PW; Ebbe, SN; Kullgren, B; Raymond, KN; Rosen, CJ; Shuh, DK; Xu, J | 1 |
| Devilliers, K; Grémy, O; Miccoli, L | 1 |
3 other study(ies) available for pentetic acid and lithium
| Article | Year |
|---|---|
Renal effects of hyperinsulinaemia in subjects with two hypertensive parents.
Topics: Adult; Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Kidney; Lithium; Male; Metabolic Clearance Rate; Parents; Pentetic Acid; Potassium; Sodium; Statistics, Nonparametric | 1999 |
Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
Topics: Actinoid Series Elements; Administration, Oral; Biomimetic Materials; Cell Line; Chelating Agents; Decontamination; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Ligands; Lithium; Organometallic Compounds; Pentetic Acid; Pyridones; Time Factors | 2010 |
Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats.
Topics: Animals; Chelating Agents; Chelation Therapy; Lithium; Lung; Pentetic Acid; Plutonium; Rats | 2023 |